Clinical trials
Expanded access Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
No trials to chart.
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| No longer available | 15 |
| Available | 12 |
| Approved for marketing | 8 |
| Temporarily not available | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 2 |
| Bristol-Myers Squibb | 2 |
| Monopar Therapeutics | 2 |
| Pfizer | 2 |
| University Hospital Tuebingen | 2 |
| AVM Biotechnology Inc | 1 |
| Agenus Inc. | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| AstraZeneca | 1 |
| BTG International Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 37 |
| Recurrence | 5 |
| Lymphoma | 3 |
| Brain Neoplasms | 2 |
| Breast Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Glioma | 2 |
| Leukemia | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Neoplasms by Histologic Type | 2 |
Trials
Showing 26 to 37 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.